Linglong Tang

31PUBLICATIONS
102CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMicro- and nanosystemsMedical infection agents (incl. prions)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jul 01, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.

|Jun 10, 2026
TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial.

|Apr 15, 2026
Multi-omic characterization of nasopharyngeal carcinoma delineates the subtype-specific landscape of response to induction chemotherapy.

|Mar 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma.

Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang

|Mar 10, 2026
TOLLIP targets GSDME-NT-carrying endocytic vesicles for autophagy to regulate pyroptosis and chemotherapy efficacy.

Zhimin Xu, Zhe Li, Zhenji Deng

|Mar 06, 2026
Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials.

Sai-Wei Huang, Ye-Lin Liang, Ya-Lan Tao

Pageof 6

Frequent Collaborators

26 joint publications

Jun Ma

18 joint publications

Ying Sun

8 joint publications

Na Liu

7 joint publications

Xu Liu